JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women
Faeghi, Fariborz; Baniasadipour, Banafsheh; Jalalshokouhi, Jalal;
  PDF(new window)
 Abstract
Purpose: To make a comparison of single voxel magnetic resonance spectroscopy (SV-MRS) and dynamic contrast enhancement (DCE) MRI for differentiation of benign and malignant breast lesions in a sample of Iranian women. Materials and Methods: A total of 30 women with abnormal breast lesions detected in mammography, ultrasound, or clinical breast exam were examined with DCE and SV-MRS. tCho (total choline) resonance in MRS spectra was qualitatively evaluated and detection of a visible tCho peak at 3.2 ppm was defined as a positive finding for malignancy. Different types of DCE curves were persistent (type 1), plateau (type 2), and washout (type 3). At first, lesions were classified according to choline findings and types of DCE curve, finally being compared to pathological results as the standard reference. Results: this study included 19 patients with malignant lesions and 11 patients with benign ones. While 63.6 % of benign lesions (7 of 11) showed type 1 DCE curves and 36.4% (4 of 11) showed type 2, 57.9% (11of 19) of malignant lesions were type 3 and 42.1% (8 of 19) type 2. Choline peaks were detected in 18 of 19 malignant lesions and in 3 of 11 benign counterparts. 1 malignant and 8 benign cases did not show any visible resonance at 3.2 ppm so SV-MRS featured 94.7% sensitivity, 72.7 % specificity and 86.7% accuracy.Conclusions: The present findings indicate that a combined approach using MRS and DCE MRI can improve the specificity of MRI for differentiation of benign and malignant breast lesions.
 Keywords
Magnetic resonance spectroscopy;dynamic contrast enhancement MRI;breast lesions;benign;malignant;
 Language
English
 Cited by
 References
1.
Baek HM, Chen JH, Yu HJ, et al (2008). Detection of choline signal in human breast lesions with chemical-shift imaging. J Magnetic Resonance Imaging, 27, 1114-21. crossref(new window)

2.
Baltzer PA, Dietzel M (2013). Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T-systematic review and meta-analysis. Radiol, 267, 735-46. crossref(new window)

3.
Barker PB, Bizzi A, De Stefano N, et al (2009). MRS in breast cancer. In 'Clinical MR spectroscopy: techniques and applications', Eds Cambridge University Press, 229-42

4.
Begley JK, Redpath TW, Bolan PJ, et al (2012). In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature. Breast Cancer Res, 14, 207. crossref(new window)

5.
Bolan PJ, DelaBarre L, Baker EH, et al (2002). Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med, 48, 215-22. crossref(new window)

6.
Bolan PJ, Henry PG, Baker EH, et al (2004). Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med, 52, 1239-45. crossref(new window)

7.
Cecil KM, Schnall MD, Siegelman ES, et al (2001). The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treatm, 68, 45-54. crossref(new window)

8.
Fischer U (2004a). normal findings in MR mammography. In 'Practical MR mammography', Eds Thieme, 41-50

9.
Fischer U (2004b). technique and methods In 'Practical MR mammography', Eds Thieme, 11-21

10.
Hendrick RE (2008a). breast magnetic resonance imaging aquisition protocols. In 'Breast MRI: Fundamentals and Technical Aspects', Eds 69-135

11.
Hendrick RE (2008b). contrast agents in breast magnetic resonance imaging In 'Breast MRI: Fundamentals and Technical Aspects', Eds 113-34

12.
Huang W, Fisher PR, Dulaimy K, et al (2004). Detection of Breast Malignancy: Diagnostic MR Protocol for Improved Specificity 1. Radiol, 232, 585-91. crossref(new window)

13.
Jacobs MA, Barker PB, Argani P, et al (2005). Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imag, 21, 23-8. crossref(new window)

14.
Jafari M, Nakhaee N, Goudarzi R, et al (2014). Participation of the Women Covered by Family Physicians in Breast Cancer Screening Program in Kerman, Iran. Asian Pac J cancer prevention, 16, 4555-61.

15.
Katz-Brull R, Lavin PT, Lenkinski RE (2002). Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J National Cancer Inst, 94, 1197-203. crossref(new window)

16.
Kousi E, Tsougos I, Vasiou K, et al (2012). Magnetic resonance spectroscopy of the breast at 3T: pre-and post-contrast evaluation for breast lesion characterization. Scientific world J, 2012.

17.
Kuhl CK, Mielcareck P, Klaschik S, et al (1999). Dynamic breast mr imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? 1. Radiol, 211, 101-10. crossref(new window)

18.
Kvistad KA, Bakken IJ, Gribbestad IS, et al (1999). Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy. J Magn Reson Imaging, 10, 159-64. crossref(new window)

19.
Mackinnon WB, Barry PA, Malycha PL, et al (1997). Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiol, 204, 661-6. crossref(new window)

20.
Melsaether A, Gudi A (2014). Breast Magnetic resonance imaging performance: safety, techniques, and updates on diffusion-weighted imaging and magnetic resonance spectroscopy. Topics Magn Reson Imaging, 23, 373-84. crossref(new window)

21.
Menezes GL, Knuttel FM, Stehouwer BL, et al (2014). Magnetic resonance imaging in breast cancer: A literature review and future perspectives. World J Clinical Oncol, 5, 61. crossref(new window)

22.
Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91. crossref(new window)

23.
Orel SG (1999). Differentiating Benign from Malignant Enhancing Lesions Identified at MR Imaging of the Breast: Are Time-Signal Intensity Curves an Accurate Predictor? 1. Radiol, 211, 5-7. crossref(new window)

24.
Roebuck JR, Cecil KM, Schnall MD, et al (1998). Human breast lesions: characterization with proton MR spectroscopy. Radiol, 209, 269-75. crossref(new window)

25.
Sardanelli F, Fausto A, Di Leo G, et al (2009). In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. AmJ Roentgenol, 192, 1608-17. crossref(new window)

26.
Sharifian A, Pourhoseingholi MA, Emadedin M, et al (2015). Burden of Breast Cancer in Iranian Women is Increasing. Asian Pac J Cancer Prev, 16, 5049-52. crossref(new window)

27.
Stanwell P, Gluch L, Clark D, et al (2005). Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol, 15, 1037-43. crossref(new window)

28.
Tan J, Xu L, Yao W, et al (2015). In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a metaanalysis. Tumor Biol, 36, 345-52. crossref(new window)

29.
Yeung DKW, Cheung HS, Tse GMK (2001). Human Breast Lesions: Characterization with Contrast-enhanced in Vivo Proton MR Spectroscopyac"Initial Results 1. Radiol, 220, 40-6. crossref(new window)